INFLAMMATORY BREAST-CARCINOMA

Inflammatory breast cancer (IBC) is a rare subtype of breast cancer tr aditionally associated with an extremely poor prognosis. The appearanc e of the effected breast can be misleading, with the incorrect diagnos is of an infective process, rather than a malignant disease, further d elaying treatment. Compared with the results achieved by monotherapy w ith either surgery, radiotherapy or chemotherapy; multimodality treatm ents have achieved significant improvements in both disease-free and o verall survival. The purpose of this article is to provide a comprehen sive review of the current literature and highlight those areas where potential advances in the overall management of IBC have been made.